Quick Takeaways
- Robert Weinstein has 4 issuer positions tracked on this page.
- Estimated disclosed ownership value: $263,063.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Robert Weinstein
- Location
- Las Vegas, NV
- Summary
- The estimated net worth of Robert Weinstein is at least $263,063 dollars as of 02 Apr 2026. Robert Weinstein is the Chief Financial Officer of TAO Synergies Inc. and owns shares of TAO Synergies Inc. (TAOX) stock worth about $119.8K. Robert Weinstein is the Director of XWELL, Inc. and owns shares of XWELL, Inc. (XWEL) stock worth about $101.2K. Robert Weinstein is the Director of PharmaCyte Biotech, Inc. and owns shares of PharmaCyte Biotech, Inc. (PMCB) stock worth about $42.1K.
- Signature
- /s/ Robert Weinstein
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Robert Weinstein and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
What Changed
- Largest disclosed position: TAO Synergies Inc. ($119,830).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Robert Weinstein
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| TAOX | TAO Synergies Inc. | Chief Financial Officer | $119,830 | 06 Aug 2025 | ||
| XWEL | XWELL, Inc. | Director | $101,158 | 27 Feb 2026 | ||
| PMCB | PharmaCyte Biotech, Inc. | Director | $42,075 | 31 Mar 2026 | ||
| TWAV, OBLG | Oblong, Inc. | Director | 29 May 2023 |
Insider Transactions Reported by Robert Weinstein:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.